Moleculera Biosciences

The Autoimmune Brain Panel (formerly the Cunningham Panel) can help determine whether neuropsychiatric symptoms may be due to an autoimmune dysfunction.

[Moleculera Biosciences @MoleculeraBio]

We were pleased to participate in this year's #ILADS conference! Dr. Shimasaki presented on "The Emerging Role of CaMKII?: How Tick-Borne and Other Pathogens can active Calmodulin-Dependent Protein Kinase II in Neuronal Cells leading to Chronic Neuropsychiatric Symptoms.

[Moleculera Biosciences @MoleculeraBio]

Did you know infections, such as strep, can trigger OCD-like symptoms?

Grace was a healthy 5-year-old before a strep infection triggered OCD behaviors, unexplained rages, extreme mood swings and anxiety.

https://t.co/zfWqsXcHJ0

#ocdawarenessweek

[Moleculera Biosciences @MoleculeraBio]

Today is PANDAS Awareness Day! We're grateful to all the clinicians & researchers who have paved the way for greater understanding of this disorder.

We are honored to have helped over 2,500 clinicians & 15,500 patients worldwide identify an underlying autoimmune encephalopathy.

[Moleculera Biosciences @MoleculeraBio]

We have partnered with BioSymetrics to develop treatment-predictive algorithms based on outcomes of over 15,000 patients tested with the Autoimmune Brain Panel.

https://t.co/oUva4d253P

[Moleculera Biosciences @MoleculeraBio]

Dr. Shimasaki discusses the role of infections and immune dysfunction in neuropsychiatric disorders at this year's Mast Cell Masterminds Conference!

[Moleculera Biosciences @MoleculeraBio]

We are excited to welcome Dr. Robert Mozayeni to our Medical and Clinical Advisor Board!

Dr. Mozayeni is an accomplished physician, researcher, and leader in the fields of infectious disease and immune-mediated responses.
https://t.co/jxfyyi3KLB

[Moleculera Biosciences @MoleculeraBio]

How do infections impact the immune system and the brain, leading to neurologic and psychiatric symptoms?

Join Dr. Craig Shimasaki for a presentation and Q&A session.

Register: https://t.co/Pt7zxMNMGG

[Moleculera Biosciences @MoleculeraBio]

Patients & Parents: Join Dr. Craig Shimasaki as he discusses the biological process behind autoimmune neuropsychiatric disorders & reviews patient cases. Live Q&A to follow!

Register: https://t.co/d3YKwMXdEW

[Moleculera Biosciences @MoleculeraBio]

Study finds children with #tic disorders had significantly elevated levels of pro-inflammatory cytokines - IL-1β, TNF-α, IL-6 and IL-4 expression.
https://t.co/YwQ5X9bcZP

[Moleculera Biosciences @MoleculeraBio]

This study reviews immunomodulating treatments that could be applied for controlling neuroinflammation in patients with #autism spectrum disorder.
https://t.co/hWGsRSdgV2

[Moleculera Biosciences @MoleculeraBio]

A new study has found that patients diagnosed with schizophrenia or another psychotic disorder are three times more likely to have Bartonella DNA in their blood than adults without these disorders.
https://t.co/PZzZ6VuR4j

[Moleculera Biosciences @MoleculeraBio]

Webinar recording now available! "Immune Dysfunction & Neuropsychiatric Disorders: The role of CaMKII in the Autoimmune Brain Panel" - you can now access the recording! Thanks to the @AcadOfNutriMed for hosting. https://t.co/sklmx3Pp58

[Moleculera Biosciences @MoleculeraBio]

We are excited to welcome Dr. Vijay Aggarwall as Chairman of the Board! Dr. Aggarwall brings decades of experience in pharmaceutical services, diagnostics, and medical devices to the position.
https://t.co/KYK80j7MYm

[Moleculera Biosciences @MoleculeraBio]

We have entered into a strategic alliance with Quest Diagnostics. https://t.co/RzA0tXCL5r

[Moleculera Biosciences @MoleculeraBio]

“In this case, the [PANDAS] patient not only did not respond to antibiotic therapy but also failed to respond to conventional psychotherapy with SSRIs. He did, however, respond exceedingly well to antidopaminergic pharmacotherapy.” #PANDAS #treatment

https://t.co/4RY7IG9DAB

[Moleculera Biosciences @MoleculeraBio]

The Cunningham Panel of tests helps identify autoimmune-induced neuropsychiatric symptoms in a patient initially diagnosed with bipolar disorder.

Full report: https://t.co/m3poJyfRLD

[Moleculera Biosciences @MoleculeraBio]

Moleculera Labs welcomes Rodney Cotton, former Senior VP, Roche Diagnostics, to its Board of Directors.
https://t.co/NMsoUikeiX

[Moleculera Biosciences @MoleculeraBio]

IVIG improves multiple neuropsychiatric symptoms in PANS patients

“Improvement was primarily seen in memory (58%), sensory-motor (37%) and visual-motor integration (30%).”

https://t.co/MJmLtNEVf8